Tradestie Institutional Equity Comparison Engine

RENX vs AIMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AIMD Overall Edge

AIMD Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ainos, Inc. Common Stock (AIMD) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RENX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AIMD at 13.9x Forward P/E and -101210.2% operating margin (-96.7% YoY). In options structure, RENX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AIMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AIMD
RENX N/M vs AIMD 13.9x Fwd P/E
Growth & Margin Winner AIMD
Op Margin N/A vs -101210.2% ยท YoY N/A vs -96.7%
Momentum & Technical Winner AIMD
1Y +163.6% vs -41.6% ยท 52W Pos 19% vs 22%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RENX US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap N/A
1M Return -48.21%
1Y Return +163.59%
Forward P/E N/M
Unified AI Score
44.0 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 64.0
AIMD NASDAQ
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap $8.4M
1M Return +39.79%
1Y Return -41.58%
Forward P/E 13.9x
Unified AI Score
23.4 / 100 STRONG SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RENX +163.59% AIMD -41.58% Spread: +207.66 pp (RENX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RENX TTM Op. Margin: N/A AIMD TTM Op. Margin: -101210.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RENX vs AIMD. Trailing 12-month operating profitability (RENX N/A vs AIMD -101210.2%) and valuation multiples (RENX N/M vs AIMD 13.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RENX (2) vs AIMD (8)
Institutional Metric RENX AIMD Criterion Row Winner
Market Capitalization Scale N/A $8.4M Larger Scale AIMD
Trailing P/E Ratio Valuation N/M 13.9x Lower Multiple AIMD
Forward P/E Ratio Valuation N/M 13.9x Lower Multiple AIMD
Revenue Growth (YoY) Growth N/A -96.7% Higher Growth AIMD
Operating Margin (TTM) Profitability N/A -101210.2% Higher Margin AIMD
Net Profit Margin Profitability N/A 0.0% Higher Margin AIMD
Return on Equity (ROE) Capital Efficiency N/A -196.3% Higher ROE AIMD
52-Week Range Position Momentum 19% ($0โ€“$3) 22% ($0โ€“$4) Stronger Trend AIMD
Beta / 30D Volatility Risk Regime -17.85ฮฒ ยท 161% Vol 2.03ฮฒ ยท 437% Vol Lower Realized Risk RENX
Unified Institutional Score Composite Signal 44.0 / 100 (HOLD) 23.4 / 100 (STRONG SELL) Higher Composite RENX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RENX vs AIMD Buy Guide
RENX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RENX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AIMD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AIMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RENX nor AIMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.